welcome to Premium!
We hope you love it! Get started by browsing any of the Premium articles or individual molecule case studies here:
Please let us know about any feedback or suggestions you might have at info@drughunter.com
Drug Discovery Resources
- Drug Discovery Resources
- Drug Discovery Posters and Cheat Sheets
- Drug Discovery IPOs and Industry Reviews
- Lists of Approved Drugs
- Classics in Drug Discovery
- Drug Discovery Books
- Drug Discovery Conferences
- What is a Drug Hunter?
- Topliss Tree and Topliss Scheme Posters
- PK Reference Table / Cheat Sheet
- Pd-Couplings Table / Cheat Sheet
Highlights
-
- Molecules of the Month
January
The first, approved non-covalent BTKi, a next-generation oral SERD, a bioactive metabolite of a GHSR1a inverse agonist with the…
1 min read
-
- Article
Molecules of the Month – February 2023
A Merck HIV inhibitor with targeted cell-killing activity as a possible approach to finally eradicate HIV, a KIT-selective inhibitor…2 mins read
-
- Article
Terlipressin: Longer Peptide Effect Half-Life via an Active Metabolite
On Monday, Mar. 27th (12:15 PM ET), our Drug Hunter team will be sponsoring a luncheon at ACS Spring…5 mins read
-
- Article
Molecules of the Year 2022
In 2022, Drug Hunter highlighted 120 Molecules of the Month with structures or stories that were published for the…1 min read
-
- Approval Reviews
- Premium
2022 Drug Approvals
In 2022 there were 36 novel small molecule and large molecule drugs approved by the FDA, including 18 first-in-class…10 mins read
-
- Industry Reviews
Artificial Intelligence and Machine Learning in Drug Discovery (Part I)
In a recent webinar, we surveyed our audience and were surprised to see that a significant majority of attendees…8 mins read